Nurochek by Headsafe

What Nurochek by Headsafe does

Headsafe IP Pty Ltd (operating as Headsafe MFG Pty Ltd and marketed as 'Nurochek by Headsafe') is an Australian medical-technology company that develops and manufactures Nurochek, an FDA-cleared portable brain scanner designed for objective concussion assessment. The device uses EEG (electroencephalography) and Visual Evoked Potential (VEP) sensors combined with proprietary AI-supported algorithms that analyze more than 400,000 data points per scan and benchmark the results against normative data, producing an objective brain-function readout in approximately two minutes without requiring a pre-injury baseline. The core technology is protected by 7 granted international patents and is supported by 8 years of proprietary research and multi-site clinical validation across Australia, New Zealand, and the United States; the company also holds ISO 13485:2016 certification for medical-device manufacturing.

Nurochek targets four primary use cases: emergency medicine departments, sports medicine programs (including sideline athletic-trainer workflows), urgent care centers, and imaging centers that need functional brain data to complement structural CT/MRI imaging. The product is positioned as a replacement or supplement to subjective concussion testing (symptoms, balance, memory), which the company cites as leaving 50% of the 60 million annual worldwide concussions undetected. The product is sold for ages 12–44 and is intended for healthcare professionals rather than direct consumer use.

The business model is hardware sales of the FDA-cleared Nurochek device paired with a secure cloud platform for analysis, distributed through a combination of direct enterprise field sales and international distribution partners, with quote-based enterprise pricing (no public list price). The company is privately held, headquartered in North Sydney, Australia, with 1–10 disclosed employees and founder Dr. Adrian Cohen serving as Founder and Chief Innovation Officer.

Name

Nurochek by Headsafe

Legal name

Headsafe MFG Pty Ltd

Website

https://nurochek.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Headsafe develops Nurochek, an FDA-cleared portable EEG/VEP brain scanner that delivers objective concussion assessment in 2 minutes, targeting emergency medicine, sports medicine, urgent care, and imaging centers across Australia, New Zealand, and the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

North Sydney

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Nurochek Device Sales: Sale of FDA-cleared portable EEG/VEP brain scanning hardware device. The compact headset is the primary product platform enabling brain assessment in various clinical settings.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Headsafe manufactures and sells Nurochek™, an FDA-cleared portable brain scanner that uses EEG and Visual Evoked Potential (VEP) technology combined with proprietary AI/machine-learning algorithms to deliver objective concussion assessment in approximately two minutes without requiring a pre-injury baseline. The compact headset analyzes over 400,000 data points per scan against normative data and is deployed across emergency medicine, sports medicine, urgent care, and imaging center settings.

Product overview

Headsafe™ offers Nurochek™, a single unified FDA-cleared portable brain scanner product that uses EEG and Visual Evoked Potential (VEP) technology to provide objective concussion assessment in 2 minutes without requiring a baseline comparison. The product portfolio consists of the Nurochek™ device as the core offering, along with its companion software platform, secure cloud platform for data analysis, and solution-specific implementations for emergency medicine, sports medicine, urgent care, and imaging centers. The device is protected by 7 international patents and validated through multi-site studies across Australia, New Zealand, and the United States.

Differentiator

Problem solved

Functional benefit

Brands

• Nurochek: FDA-cleared portable brain scanner using EEG and Visual Evoked Potential (VEP) technology for objective concussion assessment in 2 minutes without baseline requirement.

Products and services

• Nurochek™ Portable Brain Scanner FDA-cleared portable EEG and Visual Evoked Potential (VEP) brain scanner headset that delivers objective concussion assessment in two minutes without requiring a pre-injury baseline. The device uses proprietary AI-supported algorithms to analyze 400,000+ data points per scan against normative data, supporting clinical decision-making for patients aged 12-44 in emergency departments, sports sidelines, urgent care facilities, and imaging centers.

Quantifiable outcome

• 2-minute assessment time from start to objective results
• +2 more outcomes

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BrainScope: BrainScope is a US-based medical device company with FDA clearance for EEG-based brain injury assessment (BrainScope Ahead), directly competing with Nurochek in objective concussion/traumatic brain injury evaluation in emergency settings.
• ImPACT Applications: ImPACT Applications is the dominant provider of computerized neurocognitive testing (ImPACT and ImPACT Pediatric) for concussion baseline and post-injury assessment, serving the same clinical and sports medicine customers Nurochek targets.
• SyncThink: SyncThink (now part of Nintendo-related ventures) provides the EYE-SYNC device for objective concussion assessment using eye-tracking technology, directly competing in sports medicine and clinical concussion evaluation markets.
• Ceribell: Ceribell develops point-of-care EEG brain monitoring systems, sharing Nurochek's focus on portable EEG-based neurological assessment in clinical and emergency settings.
• C3 Logix: C3 Logix provides a multi-modal concussion assessment platform combining balance, neurocognitive, and visual testing, directly serving the same sports medicine and clinical concussion evaluation customer base as Nurochek.

Broad incumbents

• Compumedics: Compumedics is an Australian-headquartered manufacturer of clinical EEG and sleep diagnostic systems, sharing the underlying EEG technology and clinical neurology customer base, but serving a broader hospital sleep and neurology portfolio rather than concussion-specific point-of-care.
• NeuroPace: NeuroPace is an established neurotechnology company with the FDA-approved RNS System for epilepsy, sharing the neurological device space and clinical neurology customer base, but focused on implanted therapeutic neurostimulation rather than portable diagnostic assessment.
• ANT Neuro: ANT Neuro is a European manufacturer of EEG and neuroscience research systems, sharing the underlying EEG technology stack with Nurochek but serving primarily research and clinical neurology markets with a broader product portfolio.
• MindMaze: MindMaze is a neurotechnology company developing brain-computer interface and neurological assessment/rehabilitation platforms, sharing the broader digital neurotechnology space with Nurochek's AI-driven brain assessment approach.

Emerging players

• Emotiv: Emotiv is a consumer-focused EEG headset company that has expanded into research and emerging clinical applications, sharing the underlying EEG technology platform with Nurochek but operating primarily in consumer wellness and research rather than FDA-cleared clinical assessment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nurochekbyhs
• Facebookfacebook.com/NuroChekbrainhealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nurochek by Headsafe